BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15841077)

  • 1. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
    Ballestrero A; Garuti A; Bertolotto M; Rocco I; Boy D; Nencioni A; Ottonello L; Patrone F
    Br J Cancer; 2005 May; 92(10):1948-52. PubMed ID: 15841077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.
    Núñez-Villar MJ; Martínez-Arribas F; Pollán M; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Breast Cancer Res; 2003; 5(3):R65-70. PubMed ID: 12793902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.
    Krüger WH; Jung R; Detlefsen B; Mumme S; Badbaran A; Brandner J; Renges H; Kröger N; Zander AR
    Med Oncol; 2001; 18(1):33-8. PubMed ID: 11778968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood.
    Zach O; Lutz D
    J Clin Oncol; 2005 May; 23(13):3160; author reply 3160-1. PubMed ID: 15860886
    [No Abstract]   [Full Text] [Related]  

  • 9. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
    Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
    Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
    Leone F; Perissinotto E; Viale A; Cavalloni G; Taraglio S; Capaldi A; Piacibello W; Torchio B; Aglietta M
    Bone Marrow Transplant; 2001 Mar; 27(5):517-23. PubMed ID: 11313686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer.
    Mikhitarian K; Gillanders WE; Almeida JS; Hebert Martin R; Varela JC; Metcalf JS; Cole DJ; Mitas M
    Clin Cancer Res; 2005 May; 11(10):3697-704. PubMed ID: 15897566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
    Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
    Bregni M; Fleischhauer K; Bernardi M; Pescarollo A; Guggiari E; Lunghi F; Deola S; Scaramuzza S; Re F; Setola E; Monari M; Mazzi B; Servida P; Corradini P; Peccatori J
    Bone Marrow Transplant; 2006 Feb; 37(3):311-5. PubMed ID: 16400340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
    Li G; Zhang J; Jin K; He K; Wang H; Lu H; Teng L
    Biomark Med; 2011 Apr; 5(2):249-60. PubMed ID: 21473729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new comprehensive gene expression panel to study tumor micrometastasis in patients with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Gigli F; Corsini C; Giordano G; Bertolini F; Martinelli G
    Int J Oncol; 2007 Apr; 30(4):955-62. PubMed ID: 17332935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.